Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Adult |
State: | Solid |
Purity: | >98% |
Customization: |
---|
Suppliers with verified business licenses
Octreotide (SMS 201-995) is a somatostatin receptor agonist and synthetic octapeptide endogenous somatostatin analogue. Octreotide (SMS 201-995) can bind to the somatostatin receptor and mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production. Octreotide (SMS 201-995) has antitumor activity, mediates apoptosis and may also be used in disease studies in acromegaly.
Product Information
Generic name | Octreotide Acetate |
Synonyms | SMS 202-995 |
Molecular Weight | 1019.24 |
Formula | C49H66N10O10S2 |
CAS No. | 83150-76-9 |
EINECS | 1533716-785-6 |
Sequence | D-Phe-c(Cys-Phe-DTrp-Lys-Thr-Cys)-Thr-ol |
Purity | ≥98% |
Impurity | ≤0.5% |
Storage Temp. | -20ºC |
Octreotide is hormone drug that is used to treat some types of cancer. This medication is classified as an somatostatin analog. Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (e.g., carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals.
Octreotide is also used to treat a certain condition (acromegaly) that occurs when the body makes too much of a certain natural substance. Treating acromegaly helps reduce the risk of serious problems such as diabetes and heart disease.
Can be used for:
1 Treatment of acromegaly
2 Treatment of certain tumors
3 Radiolabeling in Nuclear Medicine Imaging
4 Managing Bleeding Esophageal Varices
5 Obesity
6 Treatment of Gastrointestinal Fistula
Suppliers with verified business licenses